UPDATE : Friday, August 17, 2018
상단여백
Gemvax & KAEL's benign prostatic hyperplasia treatment draws interest
Gemvax & Kael said Monday that the Nature Reviews Urology, an international...
by Lee Han-soo  |  2018-05-29 20:57
라인
Chong Kun Dang to co-market Eisai’s dementia treatment
Chong Kun Dang CEO Kim Young-joo (left) and Eisai Korea CEO Ko Hong-byung s...
by Lee Han-soo  |  2018-05-29 16:37
라인
Eli Lilly aims for migraine injection to touch down in Korea in 2019
New injections to prevent migraines with little or no side effects are now ...
by Marian Chu  |  2018-05-29 16:05
라인
Novo Nordisk Korea issues weight loss data of Saxenda
Novo Nordisk Korea published real-world study findings on its obesity treat...
by Marian Chu  |  2018-05-29 11:16
라인
Some drugs remain blockbusters even after patent expiration. Why?
What does hair loss treatment Propecia, cholesterol therapy Lipitor, and he...
by Marian Chu  |  2018-05-29 11:16
라인
US cancer institute to fund Genexine’s cancer research
Genexine and NeoImmuneTech said last Friday that the National Cancer Instit...
by Lee Han-soo  |  2018-05-28 15:22
라인
Jeil to market Pharma Research Product’s eye drop
Jeil Healthscience, a subsidiary of Jeil Pharmaceutical, said Monday that i...
by Lee Han-soo  |  2018-05-28 15:19
라인
Novartis Korea gets additional indication for Revolade
Novartis Korea’s Revolade (ingredient: eltrombopag) can now be used to trea...
by Marian Chu  |  2018-05-28 12:00
라인
Pfizer strives to save blockbuster anti-smoking drug
Pfizer Korea is struggling hard to maintain the No. 1 status of anti-smokin...
by So Jae-hyeon  |  2018-05-28 11:57
라인
Korea to review cost-effectiveness of PCV of Pfizer, GSK
The health authorities said they would start analyzing the cost-effectivene...
by Nam Doo-hyun  |  2018-05-25 15:59
라인
Korean drugmakers raid ‘pharmerging’ markets
Domestic pharmaceutical companies are accelerating their moves to enter the...
by So Jae-hyeon  |  2018-05-25 14:32
라인
‘GC Wellbeing’s placenta injection lowers stress levels’
GC Wellbeing, a subsidiary of GC, has published a study regarding Laennec’s...
by Lee Han-soo  |  2018-05-25 14:06
라인
Allergan to start P3 clinical trials on Medytox’s BTX
An analyst report by Nomura Securities noted that Allergan, Medytox’s Innot...
by Lee Han-soo  |  2018-05-25 14:06
라인
Eli Lilly Korea to launch psoriasis treatment Taltz in June
Eli Lilly Korea (CEO: Paul Henry Huibers) said it would launch its psoriasi...
by Marian Chu  |  2018-05-24 15:33
라인
HanAll to unveil immunotherapy agent at US conference
HanAll Biopharma, a subsidiary of Daewoong Pharmaceuticals, said Thursday t...
by Lee Han-soo  |  2018-05-24 15:33
라인
Korea exported drugs to Europe the most in first 4 months
Korea exported pharmaceutical products to Europe the most and medical devic...
by Nam Doo-hyun  |  2018-05-24 15:31
라인
Reyon’s suit against ViroMed dismissed over VM202 rights
A recent court decision took a massive blow to Reyon Pharmaceutical, which ...
by Nam Doo-hyun  |  2018-05-24 11:38
라인
Canada approves Daewoong’s Nabota plant
Daewoong Pharmaceutical said Thursday that it has received good manufacturi...
by Lee Han-soo  |  2018-05-24 11:11
라인
Seoul Pharma to export products to South America
Seoul Pharmaceuticals said Wednesday that it has signed memoranda of unders...
by Lee Han-soo  |  2018-05-23 17:42
라인
Local drugs to challenge Parkinson’s disease treatment Azilect
Korean drugmakers are preparing to release modified and generic drugs of Az...
by So Jae-hyeon  |  2018-05-23 15:42
여백
여백
여백
Back to Top